Clinical Trial Update: Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL [Phase 3]

View source ↗

Summary

This entry notes the completion of a Phase 3 trial investigating a treatment strategy driven by early PET response in Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Hodgkin's Lymphoma | Phase 3 | Status: COMPLETED